Clinical trial reportAnnals of internal medicinePublished
A Risk Profile Using Simple Hematologic Parameters to Assess Benefits From Baricitinib in Patients Hospitalized With COVID-19: A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-2
Regional connection
Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source
- Institutions
- Perelman School of Medicine, University of Pennsylvania
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Annals of internal medicine
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Sulfonamides; Azetidines; Pyrazoles; Purines; Immunologic Factors; Antiviral Agents; Treatment Outcome; Double-Blind Method; Adult; COVID-19; SARS-CoV-2
- PubMed ID
- 38408357
- PubMed Central ID
- PMC11595704
- Open access
- Yes, free to read
- Added to directory
- Source checked